“The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in [...]
“Work to develop a universal flu vaccine using a microneedle patch will continue at Georgia State University’s Institute for Biomedical Sciences with a $3.86 million grant from the National [...]
FluGen’s M2SR Influenza Vaccine Succeeds in Phase 2 Human Challenge Trial Against a Highly Mismatched Virus
“FluGen, Inc. today announced preliminary data from a human challenge trial with its investigational intranasal M2SR vaccine showing, for the first time, protection against a highly [...]
The 2nd Annual meeting of the Consortium took place November 7-8 in Atlanta, GA, USA. The full meeting report is posted here.
A century after the great influenza pandemic of 1918, influenza remains a major public health threat. Annual epidemics are associated with significant mortality and morbidity globally, leading to [...]
Lessons from the Great Influenza Pandemic of 1918 to Now. What do we know, and what do we need to know? The 2-day meeting will bring together members of the scientific community, public health [...]
This year, the $150K Prizes have expanded to include 3 focus areas related to vaccine discovery: Human Immunology; Computational Biology and Protein Engineering; and Neglected Parasitic Diseases.
The immune system appears to put a premium on maintaining lung function in infants infected with the influenza virus by mounting a rapid response to repair damaged cells, according to research [...]